Apremilast for moderate hidradenitis suppurativa: results of a randomized controlled trial

Effective anti-inflammatory treatments for hidradenitis suppurativa (HS) are limited.

Source: Journal of the American Academy of Dermatology - July 3, 2018 Category: Dermatology Authors: Allard R.J.V. Vossen, M.B.A. van Doorn, Hessel H. van der Zee, Errol P. Prens Source Type: research